WTC
VKTX icon

WhitTier Trust Company’s Viking Therapeutics VKTX Stock Holding History

WhitTier Trust Company’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.6K Buy
+300
New +$9.69K ﹤0.01% 1028
2025
Q4 		– Sell
-17
Closed -$505 – 1319
2025
Q3 		$505 Hold
17
– – ﹤0.01% 1238
2025
Q2 		$450 Hold
17
– – ﹤0.01% 1392
2025
Q1 		$410 Sell
17
-1
-6% -$32 ﹤0.01% 1372
2024
Q4 		$724 Buy
18
+1
+6% +$57 ﹤0.01% 1293
2024
Q3 		$1.08K Buy
+17
New +$997 ﹤0.01% 1269

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

WhitTier Trust Company's VKTX Position: Q2 2026 in Review

WhitTier Trust Company opened a new position in Viking Therapeutics (VKTX) in Q2 2026: 300 shares worth $12.6K. The stake represents ﹤0.01% of the portfolio and ranks #1028 among its holdings. This is a return to the name: WhitTier Trust Company previously reported a position in VKTX as recently as Q3 2025.

WhitTier Trust Company first reported a position in VKTX in Q3 2024 and has held it in 6 quarters since. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • WhitTier Trust Company held 300 shares of Viking Therapeutics worth $12.6K as of Q2 2026.
  • Viking Therapeutics was a new WhitTier Trust Company position in Q2 2026.
  • Viking Therapeutics made up ﹤0.01% of WhitTier Trust Company's portfolio in Q2 2026, its #1028 holding.
  • WhitTier Trust Company first reported a position in Viking Therapeutics in Q3 2024 and has held it in 6 quarters since.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on WhitTier Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.